GE HealthCare expects 8–12% EPS growth and $1.7B free cash flow in 2026 as new products ramp

GEHC Q4 2025 earnings call recap: revenue, record backlog, 2026 guidance, Intelerad deal, Flyrcado ramp, tariffs & China risks—read key takeaways.